DK1419160T3 - Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre - Google Patents

Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre

Info

Publication number
DK1419160T3
DK1419160T3 DK02767415T DK02767415T DK1419160T3 DK 1419160 T3 DK1419160 T3 DK 1419160T3 DK 02767415 T DK02767415 T DK 02767415T DK 02767415 T DK02767415 T DK 02767415T DK 1419160 T3 DK1419160 T3 DK 1419160T3
Authority
DK
Denmark
Prior art keywords
pyrrolizin
chlorophenyl
dihydro
dimethyl
phenyl
Prior art date
Application number
DK02767415T
Other languages
English (en)
Inventor
Gerd Dannhardt
Thomas Kammermeier
Philipp Merckle
Hans-Guenter Striegel
Stefan Laufer
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of DK1419160T3 publication Critical patent/DK1419160T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02767415T 2001-08-23 2002-08-21 Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre DK1419160T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141285A DE10141285A1 (de) 2001-08-23 2001-08-23 Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
PCT/EP2002/009356 WO2003018583A1 (de) 2001-08-23 2002-08-21 Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure

Publications (1)

Publication Number Publication Date
DK1419160T3 true DK1419160T3 (da) 2009-04-14

Family

ID=7696330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02767415T DK1419160T3 (da) 2001-08-23 2002-08-21 Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre

Country Status (32)

Country Link
US (1) US7078535B2 (da)
EP (1) EP1419160B1 (da)
JP (1) JP4195379B2 (da)
KR (1) KR100687472B1 (da)
CN (1) CN1266152C (da)
AR (1) AR035117A1 (da)
AT (1) ATE417047T1 (da)
AU (1) AU2002331168C1 (da)
BR (1) BR0212009A (da)
CA (1) CA2458339C (da)
CO (1) CO5560556A2 (da)
CU (1) CU23345A3 (da)
CY (1) CY1109089T1 (da)
DE (2) DE10141285A1 (da)
DK (1) DK1419160T3 (da)
EA (1) EA006436B1 (da)
ES (1) ES2319268T3 (da)
GE (1) GEP20063918B (da)
HK (1) HK1060879A1 (da)
HR (1) HRP20040263B1 (da)
HU (1) HU228125B1 (da)
IL (2) IL160047A0 (da)
MX (1) MXPA04001664A (da)
NO (1) NO328299B1 (da)
NZ (1) NZ531113A (da)
PL (1) PL367796A1 (da)
PT (1) PT1419160E (da)
RS (1) RS51877B (da)
TW (1) TWI274755B (da)
UA (1) UA75702C2 (da)
WO (1) WO2003018583A1 (da)
ZA (1) ZA200402209B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
WO2007108006A1 (en) * 2006-03-23 2007-09-27 Unichem Laboratories Limited Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
CZ2007752A3 (cs) * 2007-10-30 2009-05-13 Zentiva, A. S. Nový zpusob výroby 2-(6-(4-chlorfenyl)-2,2-dimethyl-7-fenyl-2,3-dihydro-1H-pyrrolizin-5-yl)octové kyseliny (licofelonu)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK304185A (da) 1984-07-27 1986-01-28 Hoffmann La Roche Fremgangsmaade til fremstilling af furanon
DE3915450A1 (de) 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
RS50374B (sr) 2000-01-28 2009-11-10 Merckle Gmbh., Postupak za dobijanje 6-(4-hlorfenil)-2,2-dimetil-7-fenil -2,3-dihidro-1h-pirolizin-5-il-sirćetne kiseline

Also Published As

Publication number Publication date
PL367796A1 (en) 2005-03-07
CN1545516A (zh) 2004-11-10
US7078535B2 (en) 2006-07-18
AR035117A1 (es) 2004-04-14
AU2002331168B2 (en) 2007-11-15
IL160047A0 (en) 2004-06-20
RS51877B (en) 2012-02-29
HRP20040263A2 (en) 2004-08-31
CN1266152C (zh) 2006-07-26
JP2005501871A (ja) 2005-01-20
CY1109089T1 (el) 2014-07-02
AU2002331168C1 (en) 2008-06-05
RS14604A (en) 2007-02-05
IL160047A (en) 2010-11-30
HRP20040263B1 (en) 2012-07-31
TWI274755B (en) 2007-03-01
HUP0401440A2 (hu) 2004-11-29
WO2003018583A1 (de) 2003-03-06
EA006436B1 (ru) 2005-12-29
NZ531113A (en) 2005-12-23
GEP20063918B (en) 2006-09-11
HK1060879A1 (en) 2004-08-27
NO328299B1 (no) 2010-01-25
EP1419160A1 (de) 2004-05-19
MXPA04001664A (es) 2004-05-31
CA2458339C (en) 2009-07-21
CA2458339A1 (en) 2003-03-06
HU228125B1 (en) 2012-12-28
EA200400344A1 (ru) 2004-08-26
ATE417047T1 (de) 2008-12-15
UA75702C2 (en) 2006-05-15
ES2319268T3 (es) 2009-05-06
PT1419160E (pt) 2009-03-17
ZA200402209B (en) 2005-05-11
US20040236117A1 (en) 2004-11-25
JP4195379B2 (ja) 2008-12-10
BR0212009A (pt) 2004-09-28
CO5560556A2 (es) 2005-09-30
DE10141285A1 (de) 2003-03-27
CU23345A3 (es) 2009-02-20
HUP0401440A3 (en) 2008-03-28
EP1419160B1 (de) 2008-12-10
KR20040029006A (ko) 2004-04-03
KR100687472B1 (ko) 2007-02-27
DE50213105D1 (de) 2009-01-22
NO20041178L (no) 2004-04-22

Similar Documents

Publication Publication Date Title
DK1762567T3 (da) Pyrazolderivater til behandling af HIV
DK1381351T3 (da) Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1385826T3 (da) Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid
EE200300400A (et) Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1353930T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1656365T3 (da) Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1419160T3 (da) Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1519936T3 (da) Fremgangsmåde til fremstilling af nevirapin
DK1281707T3 (da) Fremgangsmåde til fremstilling af 5-substituerede isobenzenfuraner
DK1417207T3 (da) Fremgangsmåde til fremstilling af 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-oner
DK1497290T3 (da) Fremgangsmåde til fremstilling af syresalte af gemifloxacin